A Boston College biologist argues cancer is a metabolic disease of the mitochondria, not a genetic one, and can be managed without toxicity.

Thomas Seyfried: Professor of biology, genetics, and biochemistry at Boston College who has spent 30+ years researching cancer metabolism. He champions the metabolic theory of cancer, building on Otto Warburg's work, and developed the Glucose Ketone Index for managing cancer through diet.
Thomas Seyfried makes the case that cancer is fundamentally a mitochondrial metabolic disorder rather than a genetic disease, citing evidence from nucleus-transplant experiments, cancers without mutations, and healthy people carrying 'driver' mutations. He explains that tumor cells depend on fermenting glucose and glutamine, and that restricting those two fuels while shifting the body into nutritional ketosis can slow or starve tumors. He details 'metabolic therapy' as both prevention and treatment, illustrated by case studies of a dog and brain-cancer patient Pablo Kelly who survived a glioblastoma for a decade. He is sharply critical of standard-of-care chemo, radiation, and drugs like Avastin, framing the resistance to his ideas as a paradigm shift comparable to the Copernican revolution. He stresses personal responsibility, exercise, fasting, and tracking one's Glucose Ketone Index.
Keto-Mojo
“With the with the Keto Mojo meter. You can buy it from Amazon. Okay. Okay, you can buy”— Thomas Seyfried
Abbott
“don't forget they get a free Libre meter now for the blood. They're working on ketone blood meters, but it's not there yet”— Thomas Seyfried